Qbtech receives FDA clearance for online test that assesses ADHD
Sweden-based Qbtech has received an FDA 510(k) clearance for an online tool, called QbCheck, that offers clinical decision-making support for diagnosing and treating children with ADHD. According to the company, the normal route for diagnosing ADHD is complicated, involves, administrative costs, and carries risk for bias. Qbtech’s process aims to make ADHD easier to identify, rule out, and monitor...QbCheck is similar to QbTest, except it’s all online and makes use the space bar instead of a button, and the computer’s web camera instead of a standalone camera.
Other Articles in this Edition
Increased odds of ADHD for kids with some types of vision problems
ADHD, OCD, autism: Is it time to redraw the boundaries separating childhood behavioural disorders?
Qbtech receives FDA clearance for online test that assesses ADHD
Videogame addiction linked to ADHD
ADHD Drug Does Not Heighten Suicide Risk Despite FDA Warning
Risk of drug abuse lower for teens prescribed stimulant medications early in life
Gestational exposure to type of antidepressants associated with adolescent offspring depression